Testosterone Replacement Therapy Market

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Testosterone Replacement Therapy Market contains market size and forecasts of Testosterone Replacement Therapy in global, including the following market information:
Global Testosterone Replacement Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Testosterone Replacement Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Testosterone Replacement Therapy companies in 2021 (%)
The global Testosterone Replacement Therapy market was valued at 1570.7 million in 2021 and is projected to reach US$ 1186.9 million by 2028, at a CAGR of -3.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gels Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Testosterone Replacement Therapy include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Testosterone Replacement Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Testosterone Replacement Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Testosterone Replacement Therapy Market Segment Percentages, by Type, 2021 (%)
Gels
Injections
Patches
Other
Global Testosterone Replacement Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Testosterone Replacement Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Testosterone Replacement Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Testosterone Replacement Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Testosterone Replacement Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Testosterone Replacement Therapy revenues share in global market, 2021 (%)
Key companies Testosterone Replacement Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Testosterone Replacement Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals